176 related articles for article (PubMed ID: 10534161)
21. Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Wu CD; Jackson CL; Medeiros LJ
Am J Clin Pathol; 1996 Mar; 105(3):277-85. PubMed ID: 8602607
[TBL] [Abstract][Full Text] [Related]
22. Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course.
Viaggi S; Abbondandolo A; Carbone M; Ottaggio L; Sessarego M; Zupo S; Zunino A
Cancer Genet Cytogenet; 2004 Jan; 148(2):133-6. PubMed ID: 14734224
[TBL] [Abstract][Full Text] [Related]
23. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY).
Baró C; Salido M; Espinet B; Astier L; Domingo A; Granada I; Millà F; Carrió A; Costa D; Luño E; Hernández JM; Campo E; Florensa L; Ferrer A; Salar A; Bellosillo B; Besses C; Serrano S; Solé F
Leuk Res; 2008 May; 32(5):727-36. PubMed ID: 18023866
[TBL] [Abstract][Full Text] [Related]
24. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
[TBL] [Abstract][Full Text] [Related]
25. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
26. Splenic marginal zone lymphoma with micronodular T-cell rich B-cell lymphoma.
Wang SA; Olson N; Zukerberg L; Harris NL
Am J Surg Pathol; 2006 Jan; 30(1):128-32. PubMed ID: 16330953
[TBL] [Abstract][Full Text] [Related]
27. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma.
Cuneo A; Bardi A; Wlodarska I; Selleslag D; Roberti MG; Bigoni R; Cavazzini F; De Angeli C; Tammiso E; del Senno L; Cavazzini P; Hagemeijer A; Castoldi G
Leukemia; 2001 Aug; 15(8):1262-7. PubMed ID: 11480569
[TBL] [Abstract][Full Text] [Related]
28. Blastic transformation of splenic marginal zone B-cell lymphoma.
Cualing H; Steele P; Zellner D
Arch Pathol Lab Med; 2000 May; 124(5):748-52. PubMed ID: 10782161
[TBL] [Abstract][Full Text] [Related]
29. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of marginal zone lymphoma involving bone marrow.
Kent SA; Variakojis D; Peterson LC
Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
[TBL] [Abstract][Full Text] [Related]
31. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
32. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.
Boonstra R; Bosga-Bouwer A; van Imhoff GW; Krause V; Palmer M; Coupland RW; Dabbagh L; van den Berg E; van den Berg A; Poppema S
Mod Pathol; 2003 Dec; 16(12):1210-7. PubMed ID: 14681321
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
34. Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
Munari E; Rinaldi M; Ambrosetti A; Bonifacio M; Bonalumi A; Chilosi M; Zamò A
Virchows Arch; 2012 Dec; 461(6):677-85. PubMed ID: 23064660
[TBL] [Abstract][Full Text] [Related]
35. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
[TBL] [Abstract][Full Text] [Related]
36. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
[TBL] [Abstract][Full Text] [Related]
37. Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma.
Alkan S; Ross CW; Hanson CA; Schnitzer B
Hum Pathol; 1996 May; 27(5):503-6. PubMed ID: 8621189
[TBL] [Abstract][Full Text] [Related]
38. Splenic marginal zone lymphoma. A distinct B-cell neoplasm.
Hammer RD; Glick AD; Greer JP; Collins RD; Cousar JB
Am J Surg Pathol; 1996 May; 20(5):613-26. PubMed ID: 8619426
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological features of CD5-positive splenic marginal zone lymphoma.
Li Y; Wang G; Liu E; Zhang D; Zhang Y; Jian X; Zhao W; Li W
J Clin Pathol; 2024 May; 77(6):421-425. PubMed ID: 36922019
[TBL] [Abstract][Full Text] [Related]
40. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
